LIF and breast neoplasm: Similarly, IL-6 cytokine leukemia inhibitory factor (LIF), which belongs to the IL-6 family of cytokines, was recently identified as a critical factor in cancer progression, metastasis, stem cell maintenance and therapy resistance, and represented as a breast tumor and lung metastasis suppressor (99, 100).